An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib+ radiation for newly-diagnosed glioblastoma (GBM) patients Article

cited authors

  • Chakravarti, A; Seiferheld, W; Robins, HI; Guha, A; Brachman, D; Curran, W; Choucair, A; Mehta, M

fiu authors

Digital Object Identifier (DOI)

start page

  • 1571

end page

  • 1571


  • 14_suppl